| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |